Sat.Apr 19, 2025

article thumbnail

The Key To Lowering High Cholesterol

Dr. Paddy Barrett

“I have high cholesterol, and I don’t know what to do about it.” This is one of the most common scenarios I encounter as a cardiologist focused on preventing heart disease. Unfortunately, many people do not understand cholesterol, and because of this, they wait too long to address the underlying problem. There is a very structured solution to this issue.

article thumbnail

Mobile Apps Show Promise for Improving CKD Medication Adherence

HCPLive

Several mobile apps effectively improved medication adherence in patients with CKD, posing important implications for their impact on clinical outcomes.

article thumbnail

Hearing Loss and Heart Failure; Improved TAVR Outcomes

Med Page Today

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.

TAVR 96
article thumbnail

High Costs, Shortages Stand as Barriers for Obtaining Epinephrine Autoinjectors

HCPLive

A survey reported that among 98.3% of respondents prescribed an epinephrine autoinjector for food allergies, 75.1% expressed concern about obtaining it.

90
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Do GLP-1 Receptor Agonists Improve Walking Function in Patients with PAD and Claudication?

NEJM Journal Watch - Cardiology

Yes, according to a randomized trial of semaglutide in a population with type 2 diabetes.

article thumbnail

The HCPFive: Top News for Healthcare Providers from the Week of 04/13

HCPLive

Our top 5 headlines spotlight FDA approvals for maralixibat and dupilumab, plus key trial results in diabetes, cardiovascular disease, and retinal vein occlusion.

article thumbnail

ECG Blog #478 — Torsades or Polymorphic VT?

Ken Grauer, MD

The lead II rhythm strip shown below in Figure-1 was obtained from an older man who was on multiple medications and, who presented to the hospital with shortness of breath. QUESTION: The concern regarding this rhythm strip was whether this patient was having intermittent episodes of Torsades de Pointes or of PMVT ( P oly M orphic V entricular T achycardia )?

Blog 108